1 Top Growth Stock Down 50% to Buy After Its Recent Pullback

a week ago

TransMedics quickly became the leader in liver, heart, and lung transplants, but its third-quarter earnings left the market worried. Here's why I believe its pullback in share price is an opportunity.

Ticker	Sentiment	Impact
TMDX	Bullish	75 %